Acyl-CoA

Abstract: Triacylglycerols are quantitatively the most important storage form of energy for eukaryotic cells Acyl CoA:diacylglycerol acyltransferase (DGAT, EC 23120) catalyzes the terminal and only committed step in triacylglycerol synthesis, by using diacylglycerol and fatty acyl CoA as substrates DGAT plays a fundamental role in the metabolism of cellular diacylglycerol and is important in higher eukaryotes for physiologic processes involving triacylglycerol metabolism such as intestinal fat absorption, lipoprotein assembly, adipose tissue formation, and lactation DGAT is an integral membrane protein that has never been purified to homogeneity, nor has its gene been cloned We identified an expressed sequence tag clone that shared regions of similarity with acyl CoA:cholesterol acyltransferase, an enzyme that also uses fatty acyl CoA as a substrate Expression of a mouse cDNA for this expressed sequence tag in insect cells resulted in high levels of DGAT activity in cell membranes No other acyltransferase activity was detected when a variety of substrates, including cholesterol, were used as acyl acceptors The gene was expressed in all tissues examined; during differentiation of NIH 3T3-L1 cells into adipocytes, its expression increased markedly in parallel with increases in DGAT activity The identification of this cDNA encoding a DGAT will greatly facilitate studies of cellular glycerolipid metabolism and its regulation

Abstract: Purified rat liver peroxisomes contain a cyanide-insensitive fatty acyl-CoA oxidizing system that uses O2 and NAD as electron acceptors. The system was detected by the ability of added palmitoyl-CoA to elicit O2 consumption, H2O2 production, and O2-dependent NAD reduction. The activity of this system is increased approximately one order of magnitude in rats treated with clofibrate, a hypolipidemic drug known to cause peroxisomal proliferation.

Abstract: The intracellular concentration of free unbound acyl-CoA esters is tightly controlled by feedback inhibition of the acyl-CoA synthetase and is buffered by specific acyl-CoA binding proteins. Excessive increases in the concentration are expected to be prevented by conversion into acylcarnitines or by hydrolysis by acyl-CoA hydrolases. Under normal physiological conditions the free cytosolic concentration of acyl-CoA esters will be in the low nanomolar range, and it is unlikely to exceed 200 nM under the most extreme conditions. The fact that acetyl-CoA carboxylase is active during fatty acid synthesis (Ki for acyl-CoA is 5 nM) indicates strongly that the free cytosolic acyl-CoA concentration is below 5 nM under these conditions. Only a limited number of the reported experiments on the effects of acyl-CoA on cellular functions and enzymes have been carried out at low physiological concentrations in the presence of the appropriate acyl-CoA-buffering binding proteins. Re-evaluation of many of the reported effects is therefore urgently required. However, the observations that the ryanodine-senstitive Ca2+-release channel is regulated by long-chain acyl-CoA esters in the presence of a molar excess of acyl-CoA binding protein and that acetyl-CoA carboxylase, the AMP kinase kinase and the Escherichia coli transcription factor FadR are affected by low nanomolar concentrations of acyl-CoA indicate that long-chain acyl-CoA esters can act as regulatory molecules in vivo. This view is further supported by the observation that fatty acids do not repress expression of acetyl-CoA carboxylase or Delta9-desaturase in yeast deficient in acyl-CoA synthetase.

Abstract: Dietary fatty acids specifically modulate the onset and progression of various diseases, including cancer, atherogenesis, hyperlipidaemia, insulin resistances and hypertension, as well as blood coagulability and fibrinolytic defects; their effects depend on their chain length and degree of saturation Hepatocyte nuclear factor-4alpha (HNF-4alpha) is an orphan transcription factor of the superfamily of nuclear receptors and controls the expression of genes that govern the pathogenesis and course of some of these diseases Here we show that long-chain fatty acids directly modulate the transcriptional activity of HNF-4alpha by binding as their acyl-CoA thioesters to the ligand-binding domain of HNF-4alpha This binding may shift the oligomeric-dimeric equilibrium of HNF-4alpha or may modulate the affinity of HNF-4alpha for its cognate promoter element, resulting in either activation or inhibition of HNF-4alpha transcriptional activity as a function of chain length and the degree of saturation of the fatty acyl-CoA ligands In addition to their roles as substrates to yield energy, as an energy store, or as constituents of membrane phospholipids, dietary fatty acids may affect the course of a disease by modulating the expression of HNF-4alpha-controlled genes

Abstract: Fatty acids represent a very important, if not the most important, substrate for myocardial energy metabolism. The heart derives fatty acids from circulating FFA bound to albumin and from plasma triglycerides. The rate of extraction of albumin bound FFA depends upon the albumin: FFA molar ratio and the metabolic state of the tissue. Since the albumin concentration in vivo is fairly constant, the albumin: fatty acid ratio is determined by the concentration of fatty acids in the serum. The fatty acid concentration is in turn regulated by dietary intake, de novo synthesis in the liver and adipose tissue, and the rate of fatty acid mobilization from adipose tissue. Mobilization from adipose tissue is increased during states of substrate deficiency such as fasting, diabetes or during the postabsorptive state and is decreased during periods of substrate excess. The rate of myocardial utilization of circulating triglycerides depends on the concentration of triglycerides and on the activity of lipoprotein lipases. The activity of these enzymes is under hormonal control and is increased by fasting or diabetes and is decreased by refeeding. Although the rate of FFA uptake by the heart is dependent upon the level of circulating FFA, the rate of uptake at any one concentration of exogenous FFA depends upon the metabolic state of the tissue. The rate of uptake and oxidation was increased by epinephrine (probably as a result of a positive inotropic effect) and by increased ventricular pressure development. The rate of uptake was decreased and the incorporation of fatty acids into tissue lipids was increased by reduced oxygen supply to the tissue. Regulation of fatty acid utilization by the heart is poorly understood. At low concentrations of exogenous fatty acid, the rate-limiting steps for uptake are located prior to formation of acetyl CoA. At 0.4 mM exogenous palmitate, increased ventricular pressure development accelerated the rates of oxygen consumption, CO 2 production from C 14 -palmitate and palmitate uptake. This faster rate of uptake was associated with an increased tissue content of long-chain acyl carnitine and a decreased content of long-chain acyl CoA and FFA. These data suggest that fatty acid uptake was accelerated by increased cardiac work due to an acceleration of carnitine-palmityl CoA transferase and reduced levels of tissue FFA. The lower intracellular levels of FFA would establish a larger concentration gradient between intracellular binding sites and binding sites on plasma albumin, which would accelerate transfer of exogenous fatty acid into the myocardial cells. At higher levels of exogenous fatty acids, the citric acid cycle limited the rate of fatty acid oxidation and uptake. The rate of the citric acid cycle was limited at the level of isocitrate dehydrogenase (due to a high NADHNAD ratio) and at the level of citrate synthetase (due to reduced availability of oxaloacetate). The limited rate of isocitric dehydrogenase resulted in increased tissue levels of citrate and isocitrate and decreased levels of α-ketoglutarate, succinyl CoA, malate, and oxaloacetate. Accumulation of citrate and isocitrate was limited by the availability of oxaloacetate and a limited rate of citrate synthetase resulted in accumulation of high levels of acetyl CoA. The carbon that accumulated within the cycle as citrate and isocitrate was derived from intermediates in the span of the cycle form α-ketoglurate to oxaloacetate and by converting aspartate to oxaloacetate. Low levels of oxaloacetate resulted from a high NADHNAD ratio, a limited availability of malate, due to inhibition of isocitric dehydrogenase, a reduced level of aspartate and from increased utilization by citrate synthetase. Increased ventricular pressure development accelerated the rate of NADH oxidation as indicated by a faster rate of oxygen consumption, increased the rate of flux through the citric acid cycle as shown by a faster rate of CO 2 production, and deareased the level of acetyl CoA and increased the rate of fatty acid uptake. Increased cardiac work accelerated citrate synthesis by increased levels of oxaloacetate at all levels of exogenous fatty acids that were studied. At low levels of fatty acid, increased production of oxaloacetate resulted from a stimulation of α-ketoglutarate dehydrogenase and malate dehydrogenase. At higher levels of exogenous palmitate, the primary effect of increased work was stimulation of isocitric dehydrogenase. The rate of malate dehydrogenase was also increased. These effects of cardiac work resulted from an increased rate of oxidative phosphorylation and a reduced NADHNAD ratio. Data presented indicated that translocation of long-chain acyl groups from extramitochondrial acyl carnitine to intramitochondrial acyl CoA restricted fatty acid oxidation when the level of exogenous fatty acid was low or when the tissue content of acetyl CoA was decreased by increased cardiac work at high levels of exogenous fatty acid. This restriction was bypassed and a high tissue level of acetyl CoA was maintained in hearts that were perfused with octanoate even when the rate of the citric acid cycle and the rate of octanoate uptake was accelerated twofold by increased cardiac work. With palmitate as substrate, increased cardiac work resulted in lower levels of acetyl CoA, acetyl carnitine and long-chain acyl CoA and in higher levels of long-chain acyl carnitine, indicating that carnitine:acyl CoA transferase was stimulated. Higher levels of acyl carnitine would help overcome the restriction to acyl translocation across the inner mitochondrial membrane and facilitate fatty acid oxidation. Endogenous triglycerides represent a readily available supply of substrate for energy metabolism. Oxidation of the triglyceride fatty acids stored in the tissue could support normal rates of oxygen consumption for about 45 min. Only about 50% of these fatty acids appeared to be available for oxidation. The rate of triglyceride breakdown was accelerated by increased ventricular pressure development and this effect was reduced by the presence of exogenous long-chain fatty acids, but not by short-chain acids. The rate of triglyceride synthesis was increased by greater availability of circulating fatty acids and higher tissue levels of acyl CoA or by a reduced rate of oxidative metabolism.